| BS20020011 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Import Drug Application | 2002-09-25 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Approval Completed-Pending Certificated | 2003-05-08 | view |
| CSL01011 | 曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(4) | New Drug Application | 2001-03-13 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2001-11-13 | view |
| CXSB2000101 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-24 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-11-23 | view |
| CXSL1400013 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(2) | New Drug Application | 2014-04-30 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2016-09-26 | view |
| CXSL1400077 | 注射用重组抗人表皮生长因子受体2(HER2)单抗(曲妥珠单抗) | trastuzumab | Lyophilized | Biological Products(2) | New Drug Application | 2014-09-12 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2016-07-21 | view |
| CXSS1900021 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(2) | New Drug Application | 2019-04-29 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2020-08-19 | view |
| CXSS2101019 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2021-08-05 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CXSS2200005 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2022-01-14 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CXSS2200015 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2022-02-17 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSS2300027 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2023-04-27 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSS2400099 | 注射用瑞康曲妥珠单抗 | SHR-A1811 | Lyophilized | Biological Products(1) | New Drug Application | 2024-09-14 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2000228 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-10-17 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-10-16 | view |
| CYSB2000229 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-10-17 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-10-16 | view |
| CYSB2000306 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-25 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| CYSB2000307 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-25 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2021-02-05 | view |
| CYSB2101215 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2021-10-09 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2101216 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2021-10-09 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2101224 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2021-10-14 | | | | | view |
| CYSB2101225 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2021-10-14 | | | | | view |
| CYSB2200023 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2022-01-21 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
